Skip to contentS
SkinHealth Systems Inc.
S
SKINSkinHealth Systems Inc. Q2 2024 · 10-Q
Revenue$90.59M$90.59M−22.9% vs Q2 2023 Net Income$202.00K$202.00K−94.0% vs Q2 2023 EPS Diluted-$0.10-$0.10N/M vs Q2 2023 Gross Profit$40,940,000−39.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SkinHealth Systems Inc. · CIK 1818093 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,201,000−71.8% Free Cash Flowderived$5,867,000−71.6% Margins · derivedGross margin45.2%−12.6 pt vs Q2 2023
Operating margin-24.4%−13.2 pt vs Q2 2023
Net margin0.2%−2.6 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end